newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results

MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or the "Company"), a clinical stage pharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions,